MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
The MSH6 gene is a member of the mismatch repair (MMR) gene complex that participate in DNA repair. The MSH6 protein in conjunction with MSH2 (encoded by the MSH2 gene) form a protein complex that can identify DNA errors made during DNA synthesis. These errors are then repaired by another group of MMR gene complex proteins: MLH1-PMS2. Mutations in MMR genes cause a reduction in the cells ability to repair DNA errors, therefore DNA errors accumulate over time and are responsible for tumorgenesis.
Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer or HNPCC) is an autosomal dominant hereditary cancer syndrome associated with germline mutations in the mismatch repair genes, MLH1, MSH2, MSH6, or PMS2. Patients with Lynch syndrome have an increased risk of developing colorectal cancer as well as an increased risk of ovarian, gastric, small intestine, liver, bile duct, upper urinary tract, and brain cancers.
HNPCC is most commonly caused by mutations in hMSH2 and hMLH1, but mutations in hMSH6 are present in about 10% of families with Lynch Syndrome. Tumors that demonstrate absence of expression of MSH6 are more likely to have a germline mutation in the MSH6 gene. In addition, mutations in the MSH6 gene can cause a variant of Lynch syndrome called Muir-Torre syndrome. Individuals with this condition have an increased risk of developing several uncommon skin tumors, including sebaceous adenomas and carcinomas. Multiple rapidly growing benign tumors called keratoacanthomas may also occur, usually on sun-exposed areas of skin. Endometrial carcinoma is especially common in women with Lynch syndrome cause by MSH6 gene mutations.
- As an aid in diagnosis of Lynch syndrome/hereditary nonpolyposis colorectal cancer
- Screening family members for hereditary nonpolyposis colorectal cancer
- Disease management and therapy selection
Negative results:
- Negative results decrease the likelihood but does not rule out the presence of a germline mutation in the MSH6 gene.
- Additionally, negative result does not rule out the presence of mutations in other genes involved in DNA mismatch repair genes.
Positive results:
- Positive results detected pathogenic variant in MSH6 gene are consistent with a diagnosis of Lynch syndrome.
- Testing other family members if also recommended.
Negative for mutation analyzed (No reportable variants were identified)
Whole blood (EDTA/lavender top tube).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unacceptable
- Int J Clin Oncol. 2019 Sep;24(9):999-1011. [PMID: 31273487]
- Clin Cancer Res. 2007 Apr 1;13(7):2038-45. [PMID: 17404084]
- J Natl Cancer Inst 2004;96:261-268. [PMID: 14970275]
- Clin Cancer Res. 2009 Jul 15;15(14):4622-9. [PMID: 19584161]